Myellama Therapeutics

Business Services · Canada · 1-10 Employees

View Company Info for Free

Overview

Headquarters

169 John St, Toronto, Ontario, M5T 1X3, ...

Phone Number

(647) 287-8070

Website

www.myellama.com

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Myellama Therapeutics

myellama therapeutics is a pre-clinical company focused on developing innovative immunotherapies for multiple myeloma using proprietary TACI-based bispecific nanobodies. Their unique approach harnesses specialized antibodies derived from camelids to enhance the immune response against malignant plasma cells. Targeting patients who require additional treatment options beyond current therapies, they aim to improve survival rates through cutting-edge research. The company is currently advancing its lead product to clinical testing scheduled for late 2025 while raising development capital.Explore more
Popular SearchesMyellama TherapeuticsSIC Code 87,873NAICS Code 54,541Show more

Myellama Therapeutics Org Chart

Brent Zanke, Chief Executive Officer at Myellama Therapeutics
Canada flag for contact location.
Brent Zanke

Chief Executive Officer

PhoneEmail

Is Myellama Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Earning: See what the market has to say on Myellama Therapeutics recently announced quarterly report

Product Launch: Get notified when Myellama Therapeutics launches new products

Website visits: Recent activity has been detected on your website

Congratulate Masked Content for being promoted to Masked Content at Myellama Therapeutics

Myellama Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Check if Myellama Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Check out if Myellama Therapeutics is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Funding: Get notified immidiatlly once Myellama Therapeutics has new funding data

Click to see if Myellama Therapeutics had a recent Job posting/layoffs

Recommended Actions

Find VP level buyers at Myellama Therapeutics

Find 3 more new buyers

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Myellama Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Myellama Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Myellama Therapeutics.

Top Business Services Companies

Top companies in Australia by revenue

YCBM Australia
CSIRO's Data61
Anff-nsw
The Kids Research Institute Australia
Hunter Research Foundation
View Full List

Top companies in New Zealand by revenue

Statistics Research Associates
FIANZ Halal
Science New Zealand
The Dodd-Walls Centre
Ianz
View Full List

Top companies in United Kingdom by revenue

Nuclera
NAMSA Medvance
Oxford Analytica
Astoriom
Oxford Economics
View Full List
See more top companies

Frequently Asked Questions Regarding Myellama Therapeutics

What is Myellama Therapeutics's official website?
Myellama Therapeutics's official website is www.myellama.com What is Myellama Therapeutics's Revenue?
Myellama Therapeutics's revenue is <$5 Million What is Myellama Therapeutics's SIC code?
Myellama Therapeutics's SIC: 87,873 What is Myellama Therapeutics's NAICS code?
Myellama Therapeutics's NAICS: 54,541 How many employees does Myellama Therapeutics have?
Myellama Therapeutics has 1-10 employees What industry does Myellama Therapeutics belong to?
Myellama Therapeutics is in the industry of: Business Services, Research & Development How do I contact Myellama Therapeutics?
Myellama Therapeutics contact info: Phone number: (647) 287-8070 Website: www.myellama.com What does Myellama Therapeutics do?

myellama therapeutics is a pre-clinical company focused on developing innovative immunotherapies for multiple myeloma using proprietary TACI-based bispecific nanobodies. Their unique approach harnesses specialized antibodies derived from camelids to enhance the immune response against malignant plasma cells. Targeting patients who require additiona... l treatment options beyond current therapies, they aim to improve survival rates through cutting-edge research. The company is currently advancing its lead product to clinical testing scheduled for late 2025 while raising development capital.Read More

 Is Myellama Therapeutics a public company?
Myellama Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Myellama Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.

Test Drive ZoomInfo's Directories

Browse Directories

Most Searched Industries

Construction Law Firms & Legal Services Business Services Finance Manufacturing Agriculture Software Accounting & Accounting Services Retail Healthcare Energy, Utilities & Waste Treatment Telecommunications Transportation Real Estate
People SearchCompany Search